HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Yu-Chung Chuang Selected Research
Yu-Chung Chuang Research Topics
Disease
21
Infections
09/2022 - 09/2012
10
Bacteremia
10/2021 - 11/2010
9
Sepsis (Septicemia)
01/2022 - 02/2013
7
Pneumonia (Pneumonitis)
12/2022 - 10/2012
4
Hepatitis B
02/2022 - 11/2013
4
Coinfection
02/2022 - 06/2015
4
Viremia
01/2022 - 10/2021
4
Neoplasms (Cancer)
07/2018 - 08/2014
3
Sexually Transmitted Diseases (Sexually Transmitted Disease)
02/2022 - 01/2022
3
Syphilis
10/2021 - 07/2020
3
Critical Illness (Critically Ill)
01/2017 - 08/2012
2
Diabetes Mellitus
12/2021 - 03/2020
2
Soft Tissue Infections
12/2021 - 02/2013
2
Liver Cirrhosis (Hepatic Cirrhosis)
11/2021 - 02/2015
2
Latent Tuberculosis
11/2021 - 01/2018
2
Cross Infection (Nosocomial Infection)
11/2021 - 11/2010
2
HIV Infections (HIV Infection)
09/2021 - 01/2019
2
Weight Gain
01/2021 - 03/2020
2
Tuberculosis (Tuberculoses)
01/2019 - 10/2012
2
Hepatitis A (Hepatitis, Infectious)
01/2018 - 01/2018
2
Neoplasm Metastasis (Metastasis)
01/2018 - 09/2017
2
Candidemia
01/2018 - 04/2014
2
Septic Shock (Toxic Shock Syndrome)
01/2016 - 02/2015
1
Hypersensitivity (Allergy)
11/2021
1
Fever (Fevers)
11/2021
1
Dyslipidemias (Dyslipidemia)
03/2020
1
Healthcare-Associated Pneumonia
10/2019
1
Hematologic Diseases (Blood Diseases)
10/2019
1
Ventilator-Associated Pneumonia
10/2019
1
Hematologic Neoplasms (Hematological Malignancy)
10/2019
1
Cardiovascular Diseases (Cardiovascular Disease)
08/2019
1
Chronic Hepatitis B
07/2019
1
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2019
1
Leukopenia
12/2018
1
Human Influenza (Influenza)
12/2018
1
Hyperbilirubinemia
12/2018
Drug/Important Bio-Agent (IBA)
7
Vancomycin
FDA Link
Generic
01/2022 - 09/2012
7
Anti-Bacterial Agents (Antibiotics)
IBA
01/2022 - 08/2012
6
Daptomycin
FDA Link
01/2022 - 02/2013
4
RNA (Ribonucleic Acid)
IBA
01/2022 - 01/2021
3
Vaccines
IBA
02/2022 - 01/2018
3
Transaminases (Aminotransferases)
IBA
01/2022 - 12/2018
3
Lactams
IBA
01/2022 - 02/2015
3
Racivir
IBA
01/2022 - 07/2019
3
Tenofovir (Viread)
FDA Link
07/2019 - 01/2016
3
Lamivudine (Epivir)
FDA Link
07/2019 - 11/2013
3
Pharmaceutical Preparations
IBA
01/2017 - 06/2015
2
Emtricitabine (Emtriva)
FDA Link
01/2022 - 07/2019
2
Cobicistat
IBA
01/2022 - 03/2020
2
elvitegravir
IBA
01/2022 - 03/2020
2
Carbapenems (Carbapenem Antibiotics)
IBA
11/2021 - 06/2015
2
rifapentine (Priftin)
FDA Link
11/2021 - 01/2018
2
Isoniazid (Ftivazide)
FDA Link
Generic
11/2021 - 01/2018
2
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
01/2019 - 07/2018
2
Fluconazole (Zonal)
FDA Link
Generic
01/2019 - 01/2018
2
Anaplastic Lymphoma Kinase
IBA
01/2019 - 07/2018
2
Linezolid (Zyvox)
FDA Link
10/2018 - 12/2014
2
Fluoroquinolones
IBA
02/2016 - 10/2012
2
Colistin (Coly-Mycin)
FDA Link
06/2015 - 02/2014
2
Tigecycline (Tygacil)
FDA Link
06/2015 - 02/2014
1
2- cyclohexylidenhydrazo- 4- phenyl- thiazole
IBA
09/2022
1
Fosfomycin
FDA Link
01/2022
1
Antiviral Agents (Antivirals)
IBA
01/2022
1
Antigens
IBA
01/2022
1
tenofovir alafenamide
IBA
01/2022
1
Minocycline (Cyclops)
FDA Link
Generic
01/2022
1
Cytokines
IBA
11/2021
1
drug combination tenofovir alafenamide emtricitabine bictegravir
IBA
11/2021
1
imidazole mustard (BIC)
IBA
11/2021
1
Hepatitis C Antibodies
IBA
10/2021
1
Hepatitis B Surface Antigens (HBsAg)
FDA Link
10/2021
1
Antacids
IBA
10/2021
1
Cations
IBA
10/2021
1
Reagins
IBA
09/2021
1
benzathine
IBA
09/2021
1
Anti-Retroviral Agents (Antiretroviral Agents)
IBA
01/2021
1
Antimicrobial Peptides
IBA
01/2021
1
Cytochrome P-450 CYP2B6 (CYP2B6)
IBA
01/2021
1
Aspartate Aminotransferases (Aspartate Transaminase)
IBA
07/2020
1
Alanine Transaminase (SGPT)
IBA
07/2020
1
emtricitabine tenofovir alafenamide
IBA
03/2020
1
Doripenem
FDA Link
10/2019
1
Meropenem (Merrem)
FDA Link
Generic
10/2019
1
Anti-HIV Agents (AIDS Drugs)
IBA
08/2019
1
Adenosine Triphosphate (ATP)
IBA
01/2019
1
Cephalosporins (Cephalosporin Antibiotics)
IBA
01/2019
1
Crizotinib
IBA
01/2019
1
Phosphotransferases (Kinase)
IBA
01/2019
1
Gold
IBA
01/2019
Therapy/Procedure
15
Therapeutics
01/2022 - 11/2010
4
Length of Stay
12/2022 - 08/2012
3
Highly Active Antiretroviral Therapy (HAART)
08/2019 - 01/2018
2
Art Therapy
01/2022 - 12/2020
2
Salvage Therapy
12/2018 - 02/2013
2
Critical Care (Surgical Intensive Care)
01/2016 - 10/2012
2
Catheters
02/2015 - 02/2013
1
Long-Term Care
12/2021
1
Intravenous Administration
01/2021
1
Ambulatory Care (Outpatient Care)
03/2020
1
Central Venous Catheters
01/2019